Private Equity/Manufacturing, services, health
Tata Capital Growth Fund logo

Tata Capital Growth Fund

Growth minority fund research profile

Zephyr Peacock is a growth investor in Indian small and middle-market companies benefiting from digital transformation, with a portfolio across technology-enabled businesses and essential services.

At a glance

Founded
2010
Footprint
Mumbai
Stage
Growth minority

Research profile

Read the manager in sequence.

Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.

Investment lens

Tata Capital Growth Fund uses a growth minority approach across Manufacturing, services, health.

Current evidence

Tata Capital’s FY2024–25 annual report confirms Tata Capital Growth Fund III as a live successor fund with a US$300 million target and SEBI approval, while the manager’s current Growth Fund site identifies Fund II and Fund III as Category II AIFs managed by Tata Capital. Current manager pages attribute positions including Star Health, Jana Small Finance Bank, Home First Finance, Cello World, Tata Technologies, AESPL, Auxilo, Indusface and Cnergyis to the growth-fund franchise.

Strategy

Growth minority

Sector focus

Manufacturing, services, health

AIF structure context

Indian private equity, growth, buyout and many real-asset strategies are commonly structured as Category II AIFs. Verify the specific vehicle and registration before investing.

Current signal

Tata Capital’s FY2024–25 annual report confirms Tata Capital Growth Fund III as a live successor fund with a US$300 million target and SEBI approval, while the manager’s current Growth Fund site identifies Fund II and Fund III as Category II AIFs managed by Tata Capital. Current manager pages attribute positions including Star Health, Jana Small Finance Bank, Home First Finance, Cello World, Tata Technologies, AESPL, Auxilo, Indusface and Cnergyis to the growth-fund franchise.

Investor questions

Tata Capital Growth Fund research questions

What is Tata Capital Growth Fund's investment strategy?

Tata Capital Growth Fund is covered in Rupeia's private equity research universe. The current public record describes the strategy as Growth minority, with a sector focus of Manufacturing, services, health. The profile should be read with the linked source trail and Typical route: Category II AIF context.

What portfolio evidence is available for Tata Capital Growth Fund?

The profile displays only company or asset names attributable to Tata Capital Growth Fund in the reviewed public sources: Star Health and Allied Insurance, Jana Small Finance Bank, Home First Finance, Cello World, Tata Technologies, AESPL / Igarashi Motors, Auxilo Finserve, Indusface, Cnergyis Infotech. It does not represent a complete current portfolio unless the manager has published one.

What is known about Tata Capital Growth Fund's performance or track record?

The public portfolio names Showroom B2B, Unnati, Agnit, BatX, Ripplr, Vidyut, Curefoods, Poshn, Varthana and other companies. No consolidated fund-level return is disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.

What are Tata Capital Growth Fund's fund size, fees and minimum investment?

Public fund size: The spreadsheet records approximately $300M cumulative across funds; current vintage and final close details were not confirmed on the reviewed sources.. Public terms or access information: Growth-stage India investing in technology-enabled SMEs, including financial services, agriculture and logistics. Cheque and reserve terms are not stated.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.

Who is on Tata Capital Growth Fund's investment team?

The current source record names Akhil Awasthi (Managing Partner); Pramod Ahuja (Co-Head and Partner); Sanjay Chaudhary (Partner). Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.

What risks should be reviewed before investing with Tata Capital Growth Fund?

Review entry valuation, leverage, governance rights, concentration, execution of the value-creation plan and exit timing. The current open diligence point is: Fund III final close, fund-level net returns and vehicle-by-vehicle current deployment are not publicly disclosed; Tata Capital’s broader credit and healthcare funds are not treated as part of this growth-fund record..

What is the latest public update on Tata Capital Growth Fund?

2025-09-30: Tata Capital’s FY2024–25 annual report confirms Tata Capital Growth Fund III as a live successor fund with a US$300 million target and SEBI approval, while the manager’s current Growth Fund site identifies Fund II and Fund III as Category II AIFs managed by Tata Capital. Current manager pages attribute positions including Star Health, Jana Small Finance Bank, Home First Finance, Cello World, Tata Technologies, AESPL, Auxilo, Indusface and Cnergyis to the growth-fund franchise.

Next step

Need this manager reviewed against your mandate?

Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.

Request independent diligence →